Sangamo Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Sangamo Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 58% to $176,232,000. Profit margin reached -146%. Total operating expenses were $450,237,000.
Profit Margin
| 2014 | 45.87M | -26.41M | -57.59% |
|---|---|---|---|
| 2015 | 39.53M | -40.70M | -102.94% |
| 2016 | 19.38M | -71.65M | -369.58% |
| 2017 | 36.56M | -54.56M | -149.23% |
| 2018 | 84.45M | -68.33M | -80.91% |
| 2019 | 102.42M | -75.81M | -74.02% |
| 2020 | 118.19M | -121.12M | -102.48% |
| 2021 | 110.70M | -178.29M | -161.06% |
| 2022 | 111.29M | -192.27M | -172.76% |
| 2023 | 176.23M | -257.83M | -146.3% |
SGMO Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 176.23M | 111.29M | 110.70M | 118.19M | 102.42M | 84.45M | 36.56M | 19.38M | 39.53M | 45.87M |
Cost of revenue | 221.55M | 12.10M | 9.43M | 180.64M | 145.92M | 0 | 65.72M | 0 | 67.12M | 56.74M |
Gross profit | -45.32M | 99.19M | 101.26M | -62.45M | -43.49M | 84.45M | -29.16M | 19.38M | -27.58M | -10.87M |
Operating exp. | ||||||||||
Research and development | 234.05M | 249.89M | 230.81M | 180.64M | 145.92M | 114.86M | 65.72M | 65.61M | 67.19M | 56.74M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 450.23M | 312.58M | 294.03M | 247.74M | 207.60M | 161.60M | 92.92M | 91.94M | 86.39M | 72.42M |
Operating income | -274.00M | -201.28M | -183.33M | -129.55M | -105.18M | -77.15M | -56.36M | -72.55M | -46.85M | -26.78M |
Other income (expenses), net | 11.10M | 9.43M | 5.34M | 8.77M | 9.76M | 8.26M | 1.79M | 887K | 431K | 364K |
Income before tax | -262.90M | -191.84M | -177.99M | -120.77M | -95.41M | -68.88M | -54.56M | -71.67M | -46.42M | -26.41M |
Income tax expense | -5.07M | 429K | 306K | 345K | -19.60M | 8.26M | -1.49M | -14K | -5.72M | -683K |
Net income | -257.83M | -192.27M | -178.29M | -121.12M | -75.81M | -68.33M | -54.56M | -71.65M | -40.70M | -26.41M |
Earnings per share | ||||||||||
Basic EPS | -1.48 | -1.25 | -1.23 | -0.9 | -0.68 | -0.7 | -0.7 | -1.02 | -0.58 | -0.39 |
Diluted EPS | -1.48 | -1.25 | -1.23 | -0.9 | -0.68 | -0.7 | -0.7 | -1.02 | -0.58 | -0.39 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |